Makana™ Issued Important Patent in Europe With Hopes of Accelerating Xenotransplantation Worldwide
Company in discussion with FDA regarding first-ever human clinical trial as a solution to help solve the organ donor shortage crisis MIAMI--(BUSINESS WIRE)--Makana™ Therapeutics, a global leader in the field of xenotransplantation, was granted an important European patent that will catalyze xenotransplantation efforts abroad, the company announced today. Makana is…
